Image credit – https://www.peyroniesdisease.co.uk/
Peyronie’s Disease Treatment Market Market has potentials to grow as the most influential market worldwide as it has been playing a noteworthy role in imprinting positive impacts on the international economy. The Global Peyronie’s Disease Treatment Market Market Report offers vital insights to determine and study market anticipations, market size, and competitive environment. The research is derived through primary and secondary data sources and it encompasses both qualitative and quantitative detailing.
Peyronie’s disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. Types of erectile dysfunction include psychological erectile dysfunction, priapism characterized by painful erection in the absence of sexual stimulation, and Peyronie’s disease which causes structural abnormalities of the penis.
Request a Free Sample Copy Of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/61
Global Peyronie’s Disease Treatment Market: Drivers
Approval and launch of new drugs is expected to propel growth of the global Peyronie’s disease treatment market over the forecast period. For instance, in 2013, the U.S. Food and Drug Administration approved Xiaflex (Collagenase clostridium histolyticum) from BioSpecifics Technologies Corporation for the treatment of Peyronie’s disease in adult men.
Moreover, R&D in Peyronie’s disease treatment is also expected to propel growth of the global Peyronie’s disease treatment market over the forecast period. Similarly, in July 2019, a team of researchers from Memorial Sloan-Kettering Cancer Center (U.S.) found no link between testosterone levels and the magnitude of Peyronie’s disease-associated penile deformity.
Global Peyronie’s Disease Treatment Market: Opportunities
Guidelines for Peyronie’s disease treatment are expected to offer lucrative growth opportunities for players in the global Peyronie’s disease treatment market. For instance, in May 2015, the American Urological Association presented the first ever treatment guidelines for Peyronie’s disease recommending the use of Xiaflex.
Moreover, guidelines for the treatment of Peyronie’s disease are also expected to aid in growth of the market. For instance, in 2018, the Canadian Urological Association (CUA) presented new guidelines recommending the use of remodeling technique based on Penile Traction Device of Andromedical (ANDROPEYRONIE) in combination with collagenase injections for the treatment of patients with Peyronie’s disease.
Buy this research report here: https://www.coherentmarketinsights.com/insight/buy-now/61
Market Trends:
Asia Pacific is expected to witness significant growth in the global Peyronie’s disease treatment market, owing to approval and launch of new drugs in the region. For instance, in September 2015, BioSpecifics Technologies Corp., a biopharmaceutical company, announced the first commercial sale of Xiaflex by Asahi Kasei Pharma Corporation for the treatment of Dupuytren’s contracture in Japan has triggered a $1.0 million milestone payment to BioSpecifics.
Global Peyronie’s Disease Treatment Market: Competitive Landscape
Major players operating in the global Peyronie’s disease treatment market include, Actelion Pharmaceuticals Ltd, Asahi Kasei Corporation, BioSpecifics Technologies Corporation, Endo Pharmaceuticals Inc., Eton Pharmaceutical, Petros Pharmaceuticals, Inc., and Swedish Orphan Biovitrum AB.
Global Peyronie’s Disease Treatment Market: Key Developments
Major players operating in the global Peyronie’s disease treatment market are focused on R&D to expand their product portfolio. For instance, in November 2021, Petros Pharmaceuticals, Inc. announced the expansion of its program for investigational H100, a novel patented non-invasive topical treatment under development for Peyronie’s disease.
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/61
Table of Contents:
- Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations - Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
• Market Snippet By Product Type
• Market Snippet By Application
• Market Snippet By Technology
• Market Snippet By End User
• Market Snippet By Region
o Coherent Opportunity Map (COM) - Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
• Restraints
• Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis - Global Peyronie’s disease treatment Market, By Product Type, 2021 – 2028 (US$ Million)
o Introduction
Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Reagents & Consumables
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Peyronie’s disease treatment Market, By Application, 2021 – 2028 (US$ Million)
o Introduction
Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Genomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Peyronie’s disease treatment Market, By Technology, 2021 – 2028 (US$ Million)
o Introduction
Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Microarrays
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Peyronie’s disease treatment Market, By End User, 2021 – 2028 (US$ Million)
o Introduction
Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com